Evaluation of possible cause of weight change after Metformin and pioglitazone administration in patients with type 2 diabetes
Not Applicable
- Conditions
- Diabetes mellitus.TypeII Diabetes mellitus
- Registration Number
- IRCT201102275917N1
- Lead Sponsor
- Vice chancellor for Research, Tehran university of medical science (TUMS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with known type 2 diabetes mellitus more than 30 years
Serum creatinine < 1.5 mg/dl in men and <1.4 mg/dl in women
Exclusion criteria:
Serious cardiovascular diseases
Advanced renal or hepatic diseases
Severe diabetes mellitus complications
Poor compliance
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma ghrelin. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Serum ghrelin measurement after OGTT with 75 gram glucose.
- Secondary Outcome Measures
Name Time Method